Effects of physical therapy on the postoperative day for deep vein thrombosis on patients who had the Total Knee Arthroplasty: Randomized Controlled Trial
Not Applicable
Recruiting
- Conditions
- Knee Osteoarthritis
- Registration Number
- JPRN-UMIN000033879
- Lead Sponsor
- Sonodakai Joint Replacement Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 84
Inclusion Criteria
Not provided
Exclusion Criteria
Severe cardiovascular or nervous system disease Musculoskeletal disorder Anticoagulation therapy before surgery Preoperative D-dimer value is 1.0 micrograms/ml or more With DVT on preoperative and immediately after surgery History of DVT Cognitive disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of DVT (Ultrasonic echo)
- Secondary Outcome Measures
Name Time Method Knee pain(Numerical Rating Scale) With or without Occurrence of subjective symptoms(Mood discomfort,dizziness,nausea) With or without of embolism
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does early postoperative physical therapy in JPRN-UMIN000033879 modulate coagulation cascade and inflammatory markers in TKA patients with knee osteoarthritis?
What is the comparative effectiveness of physical therapy versus enoxaparin in preventing DVT after TKA in knee osteoarthritis patients?
Which biomarkers (e.g., D-dimer, von Willebrand factor) predict response to early mobilization in TKA patients with knee osteoarthritis undergoing physical therapy?
What are the potential adverse events associated with early postoperative physical therapy in TKA patients with knee osteoarthritis?
How do combination approaches of physical therapy and anticoagulants (e.g., rivaroxaban) compare to standard care in preventing DVT after TKA?